Business news with perspective

Zebra Technologies' new machine vision ecosystem isn't just about cameras; it's a strategic play to build resilient, augmented, and hyper-efficient factories.

After securing top-tier fire safety certifications, Xeriant is launching a production run of its NEXBOARD™ panel, a green alternative to drywall.

Intellicheck’s entry into the Russell 2000 validates its growth. But what does this mean for investors and the broader fight against digital identity fraud?

After shedding its ammo business and costly legal battles, Outdoor Holding Co. is doubling down on its GunBroker.com platform with AI to drive growth.

Leveraging the World Cup stage, Dove's #TheGameIsOurs campaign confronts a silent crisis: why nearly half of girls quit sports due to body criticism.

When Cvent faced a massive M&A challenge, it turned to AI. The result? A shift from legal bottleneck to strategic powerhouse. Here’s how they did it.

With regulatory approval for its $218M deal, Firm Capital deepens its push into manufactured housing, a key affordable housing segment in Western Canada.

As Saint-Jean-Baptiste Day nears, MADD Canada's plea reveals a deeper issue: Quebec's outlier status on a road safety policy proven to save lives and money.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

A new pharma deal isn't just about medicine. It's about the AI-driven network set to dismantle the slow, costly system of drug discovery as we know it.

Chinese innovator Kandi Technologies is aggressively expanding its off-road vehicle business, a strategic pivot that bets on deep localization over pure volume.

bioAffinity Technologies' new gene-silencing therapy kills common skin cancer cells in lab studies while leaving healthy cells untouched, hinting at a future without scars.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

As Kyverna eyes a first-in-class approval for its CAR T-cell therapy, it brings in a legal and compliance veteran with a prosecutor's edge to clear the path.

A CAD$40M military contract validates NorthStar's space tech, bolsters Canada's sovereignty, and fuels its high-stakes journey to the public market.

Praxis Precision Medicines' elsunersen earns Breakthrough Therapy status, signaling a major step toward the first disease-modifying treatment for SCN2A-DEE.

A looming Azure Maps price shock forces a critical choice: absorb a massive cost increase or navigate a complex migration. The deadline is closer than you think.

How the 75-year-old denim icon is weaving its authentic heritage into the fabric of modern country music through a strategic, nationwide festival tour.

Veea Inc. bolsters its leadership to capture the booming edge AI market, but can seasoned executives overcome daunting financial hurdles and fierce competition?